Primary Total Hip Arthroplasty
17
1
2
9
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
17.6%
3 terminated out of 17 trials
75.0%
-11.5% vs benchmark
24%
4 trials in Phase 3/4
44%
4 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
Opioid Free Anesthesia in Total Hip Arthroplasty
Comparing Dual-mobility Cups Versus Unipolar Cups for Unselected Primary Total Hip Arthroplasty by Direct Anterior Approach
Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplasty
Survival of the Insignia Stem in Total Hip Arthroplasty
Prospective Single-center Long-term Observation of the SL-PLUS® MIA Stem
Retrospective Observational Cohort Study of SYMBOL CUP DM 2
Outcomes After Hypotensive Neuraxial Anesthesia in Total Hip Arthroplasty
Total Joint Arthroplasty and Sleep
Clinical Observation Study of the Hydroxylapatite-coated SL-PLUS™ Hip Shaft
Clinical Observation Study of the Hydroxylapatite-coated SLPLUS™MIA Hip Shaft
Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty
Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty
Accuracy of OPS™ Femoral Neck Resection Study
OPS™ With Direct Anterior Approach (DAA)
Obturator Nerve Block in Total Hip Arthrosplasty
Retrospective Observational Cohort Study of SYMBOL CUP DM 1
Total Hip Arthroplasty (THA): Early Load Versus Load Late